Patents by Inventor Audrius Andrijauskas

Audrius Andrijauskas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240404689
    Abstract: Described is an artificial lung ventilation device (ALV) parameter monitoring and control system including more than one ALV, a server, a remote ALV parameter monitoring and control device, and a two-way voice communication module. Each ALV has a patient identification device. The server has a layout scheme of the ALVs in the premises. The telemedicine system identifies each patient and ALV. Ventilation modes, ALV parameters, alarms, available ventilation mode and at least one ALV parameter can be monitored and changed remotely. The server with ALV and ALV parameter monitoring and control device can be connected via physical connections, wireless communication or mobile Internet. The ALV has an integrated or stand-alone IoT unit—in this case the communication in the system can be easily changed, e.g. from 4G to 5G. Also described is a telemedicine method for monitoring and controlling ventilation modes, alarms and parameters of more than one ALV.
    Type: Application
    Filed: May 30, 2023
    Publication date: December 5, 2024
    Inventors: Povilas Andrijauskas, Tomas Motuzas, Martynas Osauskas, Juozas Sadauskas, Giedrius Zukauskas, Tomas Zamaras, Audrius Andrijauskas, Tomas Jovaisa
  • Publication number: 20130317322
    Abstract: This invention provides methods and devices for individual evaluating and modifying the state of interstitial hydration of an individual.
    Type: Application
    Filed: October 21, 2011
    Publication date: November 28, 2013
    Applicant: MEDITASKS, LLC
    Inventor: Audrius Andrijauskas
  • Publication number: 20110070210
    Abstract: Decades of investigations were focused on finding “gold standard” for evaluation of plasma dilution and osmolality, blood loss evaluation and prediction of bleeding or transfusion induced changes in hematocrit and hemoglobin concentration. Addressing deficiencies of existing methods, the current invention created new combined mathematical-physiological model applicable to manually operated nomograms and software in medical monitors. The mathematical model HBS Trends is used in blood transfusion and infusion therapy nomogram—HBS Nomogram—which is based on blood hemoglobin concentration and hematocrit. It is also an easy and practical tool for recording and dynamical interpretation of plasma osmolality, blood hemoglobin concentration, hematocrit and mean corpuscular hemoglobin concentration. The HBS Nomogram is a practical system for organizing blood test results in a patient's medical records.
    Type: Application
    Filed: August 16, 2010
    Publication date: March 24, 2011
    Inventor: Audrius Andrijauskas
  • Patent number: 7788045
    Abstract: Decades of investigations were focused on finding “gold standard” for evaluation of plasma dilution and osmolality, blood loss evaluation and prediction of bleeding or transfusion induced changes in hematocrit and hemoglobin concentration. Addressing deficiencies of existing methods, the current invention created new combined mathematical-physiological model applicable to manually operated nomograms and software in medical monitors. The mathematical model HBS Trends is used in blood transfusion and infusion therapy nomogram—HBS Nomogram—which is based on blood hemoglobin concentration and hematocrit. It is also an easy and practical tool for recording and dynamical interpretation of plasma osmolality, blood hemoglobin concentration, hematocrit and mean corpuscular hemoglobin concentration. The HBS Nomogram is a practical system for organizing blood test results in a patient's medical records.
    Type: Grant
    Filed: September 1, 2006
    Date of Patent: August 31, 2010
    Assignee: Meditasks, LLC
    Inventor: Audrius Andrijauskas
  • Publication number: 20070178167
    Abstract: Decades of investigations were focused on finding “gold standard” for evaluation of plasma dilution and osmolality, blood loss evaluation and prediction of bleeding or transfusion induced changes in hematocrit and hemoglobin concentration. Addressing deficiencies of existing methods, the current invention created new combined mathematical-physiological model applicable to manually operated nomograms and software in medical monitors. The mathematical model HBS Trends is used in blood transfusion and infusion therapy nomogram—HBS Nomogram—which is based on blood hemoglobin concentration and hematocrit. It is also an easy and practical tool for recording and dynamical interpretation of plasma osmolality, blood hemoglobin concentration, hematocrit and mean corpuscular hemoglobin concentration. The HBS Nomogram is a practical system for organizing blood test results in a patient's medical records.
    Type: Application
    Filed: September 1, 2006
    Publication date: August 2, 2007
    Inventor: Audrius Andrijauskas